Latigo Biotherapeutics (NASDAQ:LTGO) Hits New 12-Month High – Here’s What Happened

Posted by Francis Steltz on Aug 21st, 2026

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO – Get Free Report)’s share price hit a new 52-week high on Friday . The company traded as high as $22.90 and last traded at $22.39, with a volume of 143831 shares traded. The stock had previously closed at $21.40.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Latigo Biotherapeutics to a “hold” rating in a research note on Saturday, August 15th.

Get Our Latest Report on LTGO

Latigo Biotherapeutics Stock Up 4.5%

Insider Buying and Selling

In related news, Director James B. Tananbaum acquired 140,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was acquired at an average price of $18.00 per share, with a total value of $2,520,000.00. Following the purchase, the director directly owned 2,008,024 shares in the company, valued at approximately $36,144,432. This trade represents a 7.49% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Foresite Capital Management V, acquired 140,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was bought at an average cost of $18.00 per share, with a total value of $2,520,000.00. Following the purchase, the insider owned 2,008,024 shares in the company, valued at $36,144,432. The trade was a 7.49% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing.

Latigo Biotherapeutics Company Profile

(Get Free Report)

Latigo Biotherapeutics Inc is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction. Its lead product candidate includes LTG-001. Latigo Biotherapeutics Inc is based in THOUSAND OAKS, Calif.